Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v13-FR
Language English French
Date Updated 2020-07-14 2020-07-13
Drug Identification Number 02382636 02382636
Brand name HYDROMORPHONE HYDROCHLORIDE INJECTION USP HYDROMORPHONE HYDROCHLORIDE INJECTION USP
Common or Proper name HYDROmorphone Hydrochloride Injection USP HP 10 HYDROmorphone Hydrochloride Injection USP HP 10
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients HYDROMORPHONE HYDROCHLORIDE HYDROMORPHONE HYDROCHLORIDE
Strength(s) 10MG 10MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS INTRAMUSCULAR INTRAVENOUS SUBCUTANEOUS
Packaging size 50mL GVL 50mL GVL
ATC code N02AA N02AA
ATC description OPIOIDS OPIOIDS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-10-22 2019-10-22
Estimated end date
Actual end date 2020-07-13 2020-07-13
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments